Kutok Jeffery

Chief Scientific Officer at Epizyme, Inc.; Chief Scientific Officer at INFINITY PHARMACEUTICALS, INC.

Sold, on record
$81k
Dollars the filings state
Form 4 sales
5
Latest Apr 11, 2022
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale INFINITY PHARMACEUTICALS, INC.Unusual
    Jun 22, 2018 2018

    Sold 14,313 shares at $2.00 ($29k)

    Kutok Jeffery, Chief Scientific Officer

    Sold 50% of holdings ($57k position)14,313 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale INFINITY PHARMACEUTICALS, INC.Unusual
    Aug 16, 2018 +55 days

    Sold 14,313 shares at $2.01 ($29k)

    Kutok Jeffery, Chief Scientific Officer

    Sold 100% of holdings ($29k position)0 shares leftFiling

  3. 3 Form 4 sale Epizyme, Inc.Plan not stated
    Apr 5, 2021 +963 days

    Sold 2,029 shares at $8.80 ($18k)

    Kutok Jeffery, Chief Scientific Officer

    Sold 3.6% of holdings ($493k position)54,028 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale Epizyme, Inc.Plan not stated
    Feb 2, 2022 +303 days

    Sold 2,556 shares at $1.37 ($4k)

    Kutok Jeffery, Chief Scientific Officer

    Sold 2.6% of holdings ($137k position)97,304 shares leftFiling

  5. 5 Form 4 sale Epizyme, Inc.Plan not stated
    Apr 11, 2022 +68 days

    Sold 2,741 shares at $0.90 ($2k)

    Kutok Jeffery, Chief Scientific Officer

    Sold 2.8% of holdings ($88k position)94,563 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (5)

Form 144 notices and Form 4 sales by Kutok Jeffery
Source
Apr 11, 2022Apr 13, 2022Epizyme, Inc.Chief Scientific OfficerForm 4 sale2,741$2k2.8%Plan not statedSEC
Feb 2, 2022Feb 4, 2022Epizyme, Inc.Chief Scientific OfficerForm 4 sale2,556$4k2.6%Plan not statedSEC
Apr 5, 2021Apr 7, 2021Epizyme, Inc.Chief Scientific OfficerForm 4 sale2,029$18k3.6%Plan not statedSEC
Aug 16, 2018Aug 17, 2018INFINITY PHARMACEUTICALS, INC.Chief Scientific OfficerForm 4 sale14,313$29k100.0%UnusualSEC
Jun 22, 2018Jun 25, 2018INFINITY PHARMACEUTICALS, INC.Chief Scientific OfficerForm 4 sale14,313$29k50.0%UnusualSEC